SUNSHINE PHARMA (06887.HK): Controlling Shareholder & Non-executive Director Zhang Yushuai Proposes to Increase Holdings by HK$300 Million – HK$600 Million

NewTimeSpace News: On 20 July 2026, SUNSHINE PHARMA (06887.HK) issued a voluntary announcement disclosing two matters: the proposed share increase by the controlling shareholder and the Company’s share repurchase.

Mr. Zhang Yushuai intends to acquire the Company’s shares on the open market through himself or entities controlled by him, planning to accumulate shareholdings valued between HK$300 million and HK$600 million within the next six months. He may further raise the investment amount at his discretion subject to market conditions. As at the date of this announcement, Mr. Zhang holds an aggregate of 293,971,756 shares directly and indirectly via controlled entities, representing approximately 51.11% of the issued shares (excluding treasury shares). The Board views the share acquisition plan as a strong vote of confidence from Mr. Zhang in the Group’s long-term prospects and intrinsic value.

On 20 July 2026, the Company repurchased 817,500 of its own shares on the open market at a total consideration of HK$26,358,936, accounting for roughly 0.14% of the total issued share capital. The repurchased shares will be held as treasury shares, and the Company may conduct further buybacks depending on market trends.